These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33051501)

  • 1. Novel use of culturomics to identify the microbiota in hospital sink drains with and without persistent VIM-positive Pseudomonas aeruginosa.
    Pirzadian J; Harteveld SP; Ramdutt SN; van Wamel WJB; Klaassen CHW; Vos MC; Severin JA
    Sci Rep; 2020 Oct; 10(1):17052. PubMed ID: 33051501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sink drains as reservoirs of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in a Belgian intensive care unit: relation to patients investigated by whole-genome sequencing.
    De Geyter D; Vanstokstraeten R; Crombé F; Tommassen J; Wybo I; Piérard D
    J Hosp Infect; 2021 Sep; 115():75-82. PubMed ID: 34111433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting spread of VIM-positive Pseudomonas aeruginosa from colonized sink drains in a tertiary care hospital: A before-and-after study.
    Pirzadian J; Voor In 't Holt AF; Hossain M; Klaassen CHW; de Goeij I; Koene HHHT; Bode LGM; Vos MC; Severin JA
    PLoS One; 2023; 18(3):e0282090. PubMed ID: 36961784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.
    Lagatolla C; Edalucci E; Dolzani L; Riccio ML; De Luca F; Medessi E; Rossolini GM; Tonin EA
    J Clin Microbiol; 2006 Jul; 44(7):2348-53. PubMed ID: 16825348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
    Patzer JA; Walsh TR; Weeks J; Dzierzanowska D; Toleman MA
    J Antimicrob Chemother; 2009 Feb; 63(2):269-73. PubMed ID: 19095681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetic acid as a decontamination method for sink drains in a nosocomial outbreak of metallo-β-lactamase-producing Pseudomonas aeruginosa.
    Stjärne Aspelund A; Sjöström K; Olsson Liljequist B; Mörgelin M; Melander E; Påhlman LI
    J Hosp Infect; 2016 Sep; 94(1):13-20. PubMed ID: 27346622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality associated with carbapenem-susceptible and Verona Integron-encoded Metallo-β-lactamase-positive Pseudomonas aeruginosa bacteremia.
    Persoon MC; Voor In't Holt AF; Wielders CCH; Gommers D; Vos MC; Severin JA
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):25. PubMed ID: 32014058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa.
    Hopman J; Meijer C; Kenters N; Coolen JPM; Ghamati MR; Mehtar S; van Crevel R; Morshuis WJ; Verhagen AFTM; van den Heuvel MM; Voss A; Wertheim HFL
    JAMA Netw Open; 2019 Feb; 2(2):e187665. PubMed ID: 30768189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality related to Verona Integron-encoded Metallo-β-lactamase-positive
    Persoon MC; Voor In 't Holt AF; van Meer MPA; Bokhoven KC; Gommers D; Vos MC; Severin JA
    Antimicrob Resist Infect Control; 2019; 8():107. PubMed ID: 31244998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
    Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VIM-positive
    Voor In 't Holt AF; Severin JA; Hagenaars MBH; de Goeij I; Gommers D; Vos MC
    Antimicrob Resist Infect Control; 2018; 7():32. PubMed ID: 29492262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa.
    Gilarranz R; Juan C; Castillo-Vera J; Chamizo FJ; Artiles F; Álamo I; Oliver A
    Clin Microbiol Infect; 2013 Sep; 19(9):E424-7. PubMed ID: 23656535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary.
    Libisch B; Watine J; Balogh B; Gacs M; Muzslay M; Szabó G; Füzi M
    Res Microbiol; 2008 Apr; 159(3):162-8. PubMed ID: 18280707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase.
    Oh EJ; Lee S; Park YJ; Park JJ; Park K; Kim SI; Kang MW; Kim BK
    J Microbiol Methods; 2003 Sep; 54(3):411-8. PubMed ID: 12842488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of co-existing bla VIM-2 and bla NDM-1 in clinical isolates of Pseudomonas aeruginosa from India.
    Paul D; Dhar D; Maurya AP; Mishra S; Sharma GD; Chakravarty A; Bhattacharjee A
    Ann Clin Microbiol Antimicrob; 2016 May; 15():31. PubMed ID: 27154587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital.
    Merradi M; Kassah-Laouar A; Ayachi A; Heleili N; Menasria T; Hocquet D; Cholley P; Sauget M
    J Infect Dev Ctries; 2019 Apr; 13(4):284-290. PubMed ID: 32045372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.